143 related articles for article (PubMed ID: 2015734)
1. Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer.
Sandouk P; Serrie A; Urtizberea M; Debray M; Got P; Scherrmann JM
Clin Pharmacol Ther; 1991 Apr; 49(4):442-8. PubMed ID: 2015734
[TBL] [Abstract][Full Text] [Related]
2. Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF.
Wong CS; Chang YC; Yeh CC; Huang GS; Cherng CH
Can J Anaesth; 2002; 49(6):561-5. PubMed ID: 12067866
[TBL] [Abstract][Full Text] [Related]
3. Presence of morphine metabolites in human cerebrospinal fluid after intracerebroventricular administration of morphine.
Sandouk P; Serrie A; Scherrmann JM; Langlade A; Bourre JM
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():166-71. PubMed ID: 1820872
[TBL] [Abstract][Full Text] [Related]
4. Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain.
Max MB; Inturrisi CE; Kaiko RF; Grabinski PY; Li CH; Foley KM
Clin Pharmacol Ther; 1985 Dec; 38(6):631-41. PubMed ID: 2415286
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal and intraventricular morphine for pain in cancer patients: initial study.
Leavens ME; Hill CS; Cech DA; Weyland JB; Weston JS
J Neurosurg; 1982 Feb; 56(2):241-5. PubMed ID: 6172573
[TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricular application of morphine in the treatment of intractable malignant pain.
Houdek M; Opavský J; Ostrizek J
Acta Univ Palacki Olomuc Fac Med; 1990; 128():101-6. PubMed ID: 2149789
[TBL] [Abstract][Full Text] [Related]
7. CSF morphine levels after lumbar intrathecal administration of isobaric and hyperbaric solutions for cancer pain.
Caute B; Monsarrat B; Gouardères C; Verdie JC; Lazorthes Y; Cros J; Bastide R
Pain; 1988 Feb; 32(2):141-146. PubMed ID: 3362553
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of epidural morphine in man.
Nordberg G; Hedner T; Mellstrand T; Borg L
Eur J Clin Pharmacol; 1984; 26(2):233-7. PubMed ID: 6723763
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management.
Smith MT; Wright AW; Williams BE; Stuart G; Cramond T
Anesth Analg; 1999 Jan; 88(1):109-16. PubMed ID: 9895076
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic aspects of spinal morphine analgesia.
Nordberg G
Acta Anaesthesiol Scand Suppl; 1984; 79():1-38. PubMed ID: 6589939
[TBL] [Abstract][Full Text] [Related]
11. Acute decreases in cerebrospinal fluid glutathione levels after intracerebroventricular morphine for cancer pain.
Goudas LC; Langlade A; Serrie A; Matson W; Milbury P; Thurel C; Sandouk P; Carr DB
Anesth Analg; 1999 Nov; 89(5):1209-15. PubMed ID: 10553836
[TBL] [Abstract][Full Text] [Related]
12. CSF and plasma pharmacokinetics of intramuscular morphine.
Nordberg G; Borg L; Hedner T; Mellstrand T
Eur J Clin Pharmacol; 1985; 27(6):677-81. PubMed ID: 3987773
[TBL] [Abstract][Full Text] [Related]
13. CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief.
Samuelsson H; Nordberg G; Hedner T; Lindqvist J
Pain; 1987 Sep; 30(3):303-310. PubMed ID: 3670877
[TBL] [Abstract][Full Text] [Related]
14. The analgesic activity of morphine-6-glucuronide.
Osborne R; Thompson P; Joel S; Trew D; Patel N; Slevin M
Br J Clin Pharmacol; 1992 Aug; 34(2):130-8. PubMed ID: 1419474
[TBL] [Abstract][Full Text] [Related]
15. Intraventricular administration of morphine in patients with neoplastic intractable pain.
Roquefeuil B; Benezech J; Blanchet P; Batier C; Frerebeau P; Gros C
Surg Neurol; 1984 Feb; 21(2):155-8. PubMed ID: 6701752
[TBL] [Abstract][Full Text] [Related]
16. [Intracerebroventricular morphine therapy. Apropos of 79 patients].
Blond S; Meynadier J; Dupard T; Assaker R; Brichard C; Christiaens JL; Demaille A
Neurochirurgie; 1989; 35(1):52-7. PubMed ID: 2716939
[TBL] [Abstract][Full Text] [Related]
17. [Value of intraventricular morphine analgesia in intractable neoplasm pain. Apropos of 8 cases with self-administration in 4].
Roquefeuil B; Benezech J; Batier C; Blanchet P; Gros C; Mathieu-Daude JC
Neurochirurgie; 1983; 29(2):135-41. PubMed ID: 6888632
[TBL] [Abstract][Full Text] [Related]
18. Use of intraventricular and intrathecal morphine in intractable pain associated with cancer.
Nurchi G
Neurosurgery; 1984 Dec; 15(6):801-3. PubMed ID: 6549051
[TBL] [Abstract][Full Text] [Related]
19. Pain characterization in cancer patients and the analgetic response to epidural morphine.
Samuelsson H; Hedner T
Pain; 1991 Jul; 46(1):3-8. PubMed ID: 1716752
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of morphine in cerebrospinal fluid and plasma after epidural administration in man.
Drost RH; Ionescu TI; Taverne RH; van Lingen G; van Rossum JM; Maes RA
Arzneimittelforschung; 1988 Nov; 38(11):1632-4. PubMed ID: 3214449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
